Open original FDA record ↗Recall record
- FDA identifier
- Z-2336-2017
- Company in FDA record
- Arrow International Inc
- FDA record creation date
- Jun 12, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access
Source facts
- Action
- Arrow International sent an Urgent Medical Device Recall Notification Letter dated May 11, 2017, to affected customers. The firm's notification letter is requesting that customers immediately assess their current inventory and to discontinue and quarantine any product with the specific lot codes listed in the letter. In addition, customers were asked to complete the Recall Acknowledgement form and fax or email it back to Customer Service so they can receive a Returns Good Authorization Number for the product's return. Customers with questions were instructed to contact their local sales representative or Customer Service at 1-866-246-6990.
- Initiated
- 2017-05-09
- Root cause
- Packaging
- Terminated
- 2018-09-17
- Distribution
- Worldwide Distribution - US (nationwide) and Canada
- Recall number
- Z-2336-2017
- Recall status
- Terminated
- CDRH record ID
- 155538
- FDA record created
- 2017-06-12
- Recall event number
- 77232